The interferon antiviral response: From viral invasion to evasion

Current Opinion in Infectious Diseases

Volumn 15, Issue 3, 2002, Pages 259-267

  Grandvaux, Nathalie ^a   TenOever, Benjamin R ^a   Servant, Marc J ^a   Hiscott, John ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CHEMOKINE; CYTOKINE; INTERFERON; ONCOLYTIC VIRUS; ONYX 015;

APOPTOSIS; CANCER THERAPY; GENE ACTIVATION; HUMAN; IMMUNE RESPONSE; MOLECULAR MECHANICS; NONHUMAN; REOVIRUS; REVIEW; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0036105482     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200206000-00008     Document Type: Review

References (98)

1. Direct triggering of the type I interferon system by virus infection: Activation of a transcription factor complex containing IRF-3 and CBP/p300
2. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation
3. JNK2 and IKKbeta are required for activating the innate response to viral infection
4. The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome
5. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo
6. Assembly of a functional beta interferon enhanceosome is dependent on ATF-2-c-jun heterodimer orientation
7. Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter
8. Enhanceosomes
9. Cooperativity in transcriptional control
10. Nucleosome sliding via TBP DNA binding in vivo
11. Coordination of a transcriptional switch by HMGI(Y) acetylation
12. How cells respond to interferons
13. Antiviral actions of interferons
14. Viruses and interferons
15. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7
16. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-atpha/beta gene induction
17. Virus-cell interactions: Impact on cytokine production, immune evasion and tumor growth
18. Molecular pathways in virus-induced cytokine production
19. Binding of human immunodeficiency virus type 1 gp120 to CXCR4 induces mitochondrial transmembrane depolarization and cytochrome c-mediated apoptosis independently of Fas signaling
20. A novel receptor involved in T-cell activation
21. SLAM (CDw150) is a cellular receptor for measles virus
22. Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors
23. CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition
24. Induction of the measles virus receptor SLAM (CD150) on monocytes
25. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
26. Use of chemokine receptors by poxviruses
27. Poxvirus infection rapidly activates tyrosine kinase signal transduction
28. Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-kappaB
29. Virus-cell interactions regulating induction of tumor necrosis factor alpha production in macrophages infected with herpes simplex virus
30. Expression of TNF-alpha by herpes simplex virus-infected macrophages is regulated by a dual mechanism: Transcriptional regulation by NF-kappa B and activating transcription factor 2/Jun and translational regulation through the AU-rich region of the 3′ untranslated region
31. The ER-overload response: Activation of NF-kappa B
32. Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): Association with calreticulin and calnexin
33. Calcium signaling by HBx protein in hepatitis B virus DNA replication
34. Requirements for measles virus induction of RANTES chemokine in human astrocytoma-derived U373 cells
35. Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999)
36. Recognition of the measles viral nucleocapsid as a mechanism of IRF-3 activation
37. Overlapping and distinct mechanisms regulating IRF-3 and IRF-7 function
38. Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: Involvement of RNase L, protein kinase R, and alternative pathways
39. Activation of NF-kappaB by double-stranded RNA (dsRNA) in the absence of protein kinase R and RNase L demonstrates the existence of two separate dsRNA-triggered antiviral programs
40. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3
41. Disruption of Akt kinase activation is important for immunosuppression induced by measles virus
42. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation
43. Respiratory syncytial virus inhibits apoptosis and induces NF-kappa B activity through a phosphatidylinositol 3-kinase-dependent pathway
44. Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: Inhibition of PI3-K activity inhibits viral replication and virus-induced signaling
45. Gene expression array of HTLV type 1-infected T cells: Up-regulation of transcription factors and cell cycle genes
46. Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31
47. Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: Viral block to the accumulation of antiviral mRNAs
48. Herpes simplex virus triggers and then disarms a host antiviral response
49. Cellular changes induced by low-risk human papillomavirus type 11 in keratinocytes that stably maintain viral episomes
50. Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events
51. Functional classification of interferon-stimulated genes identified using microarrays
52. A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling
53. Transcriptional profiling of interferon regulatory factor 3 target genes: Direct involvement in the regulation of interferon stimulated genes
54. Gene induction pathways mediated by distinct IRFs during viral infection
55. Downregulation of IRF-3 levels by ribozyme modulates the profile of IFNA subtypes expressed in infected human cells
56. Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis
57. The IRF-3 transcription factor mediates Sendai virus-induced apoptosis
58. Apoptosis is promoted by the dsRNA-activated factor (DRAF1) during viral infection independent of the action of interferon or p53
59. Host defense, viruses and apoptosis
60. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment
61. NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis
62. NF-kappaB signaling pathway governs TRAIL gene expression and human T-cell leukemia virus-I Tax-induced T-cell death
63. Tumor necrosis factor (TNF) and phorbol ester induce TNF-related apoptosis-inducing ligand (TRAIL) under critical involvement of NF-kappa B essential modulator (NEMO)/IKKgamma
64. Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression
65. The double-stranded RNA-dependent protein kinase PKR: Structure and function
66. A new pathway of translational regulation mediated by eukaryotic initiation factor 3
67. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: Induction of interferon-responsive RNAs
68. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus
69. Vesicular stomatitis virus and pseudorabies virus induce a vig1/cig5 homologue in mouse dendritic cells via different pathways
70. MC159L protein from the poxvirus molluscum contagiosum virus inhibits NF-kappaB activation and apoptosis induced by PKR
71. African swine fever virus infection of porcine aortic endothelial cells leads to inhibition of inflammatory responses, activation of the thrombotic state, and apoptosis
72. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon
73. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein
74. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein
75. IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by Vaccinia virus E3L protein
76. Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein
77. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3
78. Specific inhibition of interferon signal transduction pathways by adenoviral infection
79. Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor
80. HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators
81. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors
82. The vesicular stomatitis virus matrix protein inhibits glycoprotein 130-dependent STAT activation
83. Viral exploitation and subversion of the immune system through chemokine mimicry
84. The Stat family in cytokine signaling
85. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway
86. Control of interferon signaling in human papillomavirus infection
87. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion
88. Longer and shorter forms of Sendal virus C proteins play different roles in modulating the cellular antiviral response
89. Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction
90. Hostile takeovers: Viral appropriation of the NF-kappaB pathway
91. PACT, a double-stranded RNA binding protein acts as a positive regulator for type I interferon gene induced by Newcastle disease virus
92. Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway
93. In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy
94. Reovirus as a novel oncolytic agent
95. Oncolytic viruses and cancer therapy
96. Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing
97. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
98. Genetically engineered vesicular stomatitis virus in gene therapy: Application for treatment of malignant disease